摘要
Abstract
Objective:To analyze the clinical effect of ticagrelor and clopidogrel in the coronary heart disease patients with percutaneous coronary intervention(PCI).Methods:90 cases of coronary heart disease patients with PCI treatment were selected. They were randomly divided into the study group and the control group with 45 cases in each.The control group was given clopidogrel treatment.The study group was given ticagrelor treatment.The changes of coagulation function index changes and platelet aggregation rate before and after treatment were compared between groups.Results:After treatment,the activated partial thromboplastin time,prothrombin time of the study group were significantly shorter than those of the control group,and the thrombin time was significantly longer than that of the control group,the fibrinogen,platelet aggregation rate were significantly lower than those of the control group(P<0.05).Conclusion:On the basis of conventional treatment,the coronary heart disease patients with PCI are given ticagrelor treatment,and the effect is significant,which can effectively improve the coagulation function of patients,reduce MPAR.关键词
替格瑞洛/氯吡格雷/经皮冠状动脉介入治疗/冠心病Key words
Ticagrelor/Clopidogrel/Percutaneous coronary intervention/Coronary heart disease
